Aspirin use may change cost-effectiveness of COX-2 inhibitors

Arch Intern Med. 2002 Dec;162(22):2637-8; author reply 2638-9. doi: 10.1001/archinte.162.22.2637-a.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspirin / administration & dosage*
  • Aspirin / economics*
  • Cohort Studies
  • Coronary Disease / drug therapy
  • Coronary Disease / prevention & control*
  • Cost-Benefit Analysis
  • Cyclooxygenase Inhibitors / administration & dosage*
  • Cyclooxygenase Inhibitors / economics*
  • Female
  • Humans
  • Male
  • Sensitivity and Specificity
  • Treatment Outcome

Substances

  • Cyclooxygenase Inhibitors
  • Aspirin